Introductionspontaneous, while in the rest of the cases it is related to dental procedures and so not classified as an acute event 7 ; (b) These drugs, particularly bisphosphonates (BFs), may remain bioavailable for several years, their action persisting a long time after therapy and/or recurring even years after the treatment 8 ; (c) Drugs holiday does not significantly improve the state of necrosis even if this strategy is considered as a prudent approach by different scientific societies 9 ; (d) The presence of compromised teeth, as well as the surgical act of their removal, can trigger the disease; (e) Otherwise, it is different from osteoradionecrosis, where bleeding bone is the sign of viable bone, in MRONJ this is not guaranteed of healthy tissue; this has led several authors to recommend a conservative approach in treating MRONJ 10 ; (f) The imbalance of bone cell turnover in osteoblastic activity seems to be an imbalance of the whole bone extracellular matrix, although there is no consensus on this 11 ; (g) Although the histology of the intraoral soft tissues appears normal, 12 these drugs also create some changes in the epithelium, so determining a deterioration of its quality. [13] [14] [15] If the disease is diagnosed in the early stage and systemic conditions are good, the curettage may be successful; in advanced cases with severe systemic disease, a more invasive approach with the use of free micro-vascularized flap with fibula or iliac crest may be necessary. 16 In the past years, bone marrow stem cells (BMSCs) have been proposed to promote healing of osteonecrotic sites, 17 due to their ability to differentiate into different human tissues, revealing a promising therapeutic option in different fields of application. The BMSC are multipotent stem cells (MSCs) able to differentiate into different human tissues and bone marrow represents a rich bank. 18, 19 The BMSC belong to the category of MSCs which, together with those of adipocytes and umbilical cord, may differentiate into different mature tissues (bone marrow, cartilage, adipose tissue, muscle, nerve). MSCs are found widely in the human body, especially in organs with high cell turnover (skin, epithelium) and they reside in niches that are 3-D micro-environments where they participate in tissue homeostasis. The mechanism by which stem cells (MSC) localize themselves is still not well defined. Very few MSC were found circulating in the peripheral blood, and when injected, they have little capacity to localize themselves in normal conditions. The difference of results between orthopedics and maxillofacial surgery use of BMSC is linked to the different quality of the surrounding tissues. Literature proposed, as an adjuvant therapy for different bone diseases, platelet-rich plasma (PRP) which is largely used in maxillofacial surgery [20] [21] [22] and in many other medical fields. The rationale for its use is the addition of growth factors (GFs) in suffering environments. PRP, in fact, contains many GFs such as fibroblast growth factor (FGF), epidermal growth factor (EGF), keratinocyte growth factor (KGF), platelet-derived growth factor (PDGF), insulin-like growth factor (IGF), vascular endothelial growth factor (VEGF), also transforming growth factor-β (TGF-β) which may modulate and prevent excessive recruitment of inflammatory leukocytes. The secretion of these factors starts with platelet activation immediately after the addition of calcium which is the cofactor necessary for the degranulation. 23 VEGF is a pleiotropic factor that activates a cascade of events inducing the revascularization of injured tissues. 24 These proteins are involved in tissue healing through cells chemotaxis, proliferation and differentiation, angiogenesis and deposition of new extracellular matrix. Reduced secretion of VEGF caused by the BF may explain the difficulty of reparation of intraoral soft tissues. 13, 25 The PRP has been shown to increase the number of BMSC to 4 times as much when administered together, thus assuming a role in potentiating the effects of BMSC. 26, 27 Although leukocytes have been proposed as additional carriers of cytokines and microbicide proteins, 28 the addition of the leukocytes to the PRP (PRP-L) did not demonstrate a difference in the bactericidal power, while platelet-derived peptides have shown a role as activators of neutrophils. 29 This property has been used to reduce the intra-operative (short therapy), to boost and eliminate the daily postoperative administration of antibiotics, and despite the dehiscence of the surgical wound, the latter phenomenon was almost constant. Piezosurgery "Piezosurgery Medical Device" (PMD) is an original surgical appliance which uses piezoelectric ultrasonic vibrations for cutting, successfully employed for performing different bone surgical procedures in the oral and maxillofacial field with great results in term of the related complications reductions. Its main advantages described are the scanty bleeding and bruising, the harmless effect on soft tissues and the low pressure needed to create bony cuts, so minimizing tissue trauma and, consequently, its associated morbidity. 30, 31 In the literature, a large case series suggested that bone resection performed by a high-power ultrasonic surgery associated with antibiotic therapy might lead to BRONJ healing. 32 Laser Laser devices are described as useful tools for different applications in the treatment of MRONJ, being able to perform the removal of necrotic bone by vaporization as well as biomodulation of both soft and hard tissues. 33, 34 Thanks to the affinity of the Er:YAG laser wavelength (2940 nm) to water and hydroxyapatite, laser technology allows for efficient ablation of hard tissues without the risk of thermal increase determining necrotic effects on tissues. Moreover, even if the classical optical window to perform biomodulating effect is in the range of 600-1000 nm of wavelength, there are some papers describing biomodulating effect also for 2940 nm wavelength. 35, 36 Er:YAG laser, thanks to the respect of tissue in terms of thermal increase and also to the biomodulating reported properties, is described as linked to a faster bone healing. 37 Bone healing is a proliferative physiological process determined by several phases and different types of tissues (periosteum, endosteum, bone marrow, blood vessels) and cells (fibroblasts, chondroblasts, osteoblasts, and osteoclasts). 38 The main effects of laser application in low-level laser therapy (LLLT) protocols on bone tissues seem to be related to the increase of bone nodule formation, blood vessels, alkaline-phosphatase (ALP) activity and osteoblastic activity, DNA synthesis, and of osteoblasts differentiation. [39] [40] [41] [42] [43] LLLT stimulates cells proliferation by the induction of cell-cycle regulatory proteins and its capacity of favoring the "in vitro" differentiation of satellite cells was demonstrated. Particularly, the induction of the mytogenactivated protein kinase/extracellular signal-regulated protein kinase (MAPK-ERK) phosphorylation was observed following LLLT irradiation. 44 The mechanism involved in the laser-induced bone repair is a two-steps sequence: the first, most likely related to the osteoblasts activation for bone matrix production, the second, subsequently, for osteoblast activity decrease and for osteoclast activity stimulation with the final result to promote resorption and remodeling of bone. LLLT seems to be more effective for the bone formation at an earlier stage instead of at a later stage, due to that in the bone healing first step, the cellular component is more important, so being more susceptible to the laser action. Moreover, because the bone matrix is the main component of the healing tissue, a great number of cells are in the bone matrix, which incorporates carbonate substituted hydroxyapatite (CHA). 45, 46 The association of Er:YAG laser bone ablation with Nd:YAG/diode laser bone biostimulation has been already reported as a successful treatment of BRONJ, supporting this kind of approach, minimally invasive and biostimulative. 33, 34, 47 The aim of this work is to present the experience of the Odontostomatology and Maxillo-Facial Surgery Unit of the Hospital of Piacenza (Italy) with a combined approach, based on the use of laser, piezosurgery and PRP, for the treatment of MRONJ.
Methods

Patients
Out of the patients evaluated at the Odontostomatology (Table 1) . Fifteen patients (71.4%) presented a mandibular localization for MRONJ, 6 (28.6%) a maxillar localization (Figure 1 ). Based on AAOMS staging system, 2 MRONJ (9.6%) were classified as Stage I, 15 MRONJ (71.4%) were classified as Stage II and 4 (19%) as Stage III. The extension and the features of the osteonecrosis were evaluated by clinical examination and radiographically with panoramic X-rays scan and CT scan. To all the patients it was prescribed an antibiotic therapy with amoxicillin+clavulanate 2 g/d and metronidazole 500 mg/d per os (or clindamycin in case of allergy), starting the therapy 3 days before surgery and interrupting the antibiotics at least 2 weeks after surgery and with a closed surgical wound. Piezosurgery PMD (Mectron, Italy) was applied to remove necrotic bone specimen of MRONJ sites allowing a histological analysis to finalize the diagnostic confirmation for MRONJ (Figures 2A-2B ). The instrument was used with a microsaw of 0.55 mm firmly moved over the bone avoiding the use of an excessive force and with an integrated saline coolant spray to maintain a low temperature and a good vision of the surgical site.
Laser Devices Er:YAG laser device (2940 nm -Lightwalker, Fotona, Slovenia) was used in the treated patients to perform vaporization of necrotic bone until the observation of Combined Approach for Jaws Osteonecrosis ). Diode laser 808 nm is a laser useful as a surgical device on soft tissues but also for biomodulation protocols depending on the parameters. It was used to perform biomodulating effect both intraoperative and postoperatively. The first session was performed just after suturing, while the subsequent ones were 2 times/ week until suture removal on a completely closed surgical wound. Biomodulation was done with a 600 µm diameter fiber in scanning mode on the surgical site with 1 W of power in continuous mode during 1 minute for 5 times (Theoretical fluence: 21231 J/cm 2 ).
Platelet Rich Plasma Autologous platelet gel was prepared at the Department of Oncology and Hematology of the Hospital of Piacenza (Italy) during the planning of the surgery and stored until the day of the intervention. Multiple samples of whole blood were obtained from each patient and collected in 10 mL vacutainers. Blood was then centrifuged at 180 rpm per 10 to separate concentrated erythrocytes from PRP and then PRP was stored at -40°C. The day of the surgery, PRP was maintained at room temperature until the use and just before that thrombin and calcium gluconate were added for platelets activation and gelling process acceleration. PRP gel was used for each patient directly on the wound, absorbed on fibrin sponge or injected with a syringe after suture directly in the wound (Figures 2D-2E) .
Results
Mean follow-up was 9.6 months. All the 21 patients (100%) experienced improvement of MRONJ with a transition to a lower stage of the Ruggero classification. Complete recovery was observed in 20 out of 21 patients (95.23%) ( Figure 2F ); one patient with mandibular BRONJ in Stage 3 and treated with the combined approach, healed completely and maintained the healing for 9 months then showed a recurrence of MRONJ on the site of intervention. All patients described a good post-operative comfort, not needing painkillers and reported the absence of bleeding and a rapid healing time. The histological evaluations performed demonstrated samples of good quality and without artifacts, allowing the confirmation of the clinical diagnosis ( Table 2) .
Discussion
Management of MRONJ is still a challenge for oral and maxillo-facial surgeons, particularly in relation with new anti-angiogenetic drugs as denosumab and sunitinib. Guidelines are today in agreement with the use of medical approach with antibiotics in all the cases, from Stage I to Stage III, in association or not with the surgical approach. 48 In our experience, as reported elsewhere in the literature, 49 an early surgical approach performed in Stage I MRONJ maybe efficient for the obtaining a complete healing with a minimally invasive surgical approach. Er:YAG laser may represent a useful option in terms of reduction of invasiveness: in fact its wavelength allows the vaporization of necrotic bone with good control of bone removal because of its affinity for water and hydroxyapatite allowing a superficial action; in addition to affinity properties, the use of a handpiece with an airwater spray limits damages the tissue avoiding temperature increase at bone level in surgical site and with this thermal necrosis. 50 These aspects are related to a good comfort during and after surgery for the patient with a reduction of postsurgical morbidity (with a reduction/elimination of pain and edema) and a better and faster healing. 51 Aoki et al reported that Er:YAG laser used for bone surgery even with high-level irradiation may induce cell reactions, thanks to the scattering phenomena surrounding the tissue irradiated, stimulating bone regeneration. 52 Ninomiya et al reported a lower number of osteoclasts after pulsed laser irradiation as well as the activation of osteoblasts with increased bone formation. 53 Pourzarandian et al reported a faster growth of cultures cells irradiated with an Er:YAG laser when compared with untreated groups thanks to the stimulation of gingival fibroblasts proliferation associated to an earlier mitosis and collagen fibril strands increment. 35 In the combined treatment we performed on these patients, beyond the biostimulating effect of Er:YAG laser, we used a biomodulating approach with a diode laser (808 nm): this kind of approach, completely safe and comfortable for the patient, may help tissue healing through the stimulation of keratinocytes, osteoblasts and endothelial cells. 54 The basis for the use of PRP is the addition of GFs as FGF, EGF, KGF, IGF, PDGF, transforming VEGF and TGF-β in suffering environments as bone exposed to the action of BFs and monoclonal antibodies; in this way, after the surgical ablation of necrotic bone and the decontamination of the surgical site, PRP may have the main role to induce tissue healing by cells chemotaxis, proliferation and differentiation, angiogenesis and deposition of new extracellular matrix. 22 Sequential utilization of different high-technologies devices during all the steps of MRONJ treatment allows to perform a faster and less invasive surgery with a more comfortable postoperative healing process and it may represent a new and original approach for treating this severe adverse event.
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